The outbreak of Wuhan pneumonia (CCP) in China has been going on for more than a year now, with more than 123 million people diagnosed and 2.72 million people dying from the disease. The number of people diagnosed with the disease has risen sharply since the vaccine was administered, and some people in the United Arab Emirates have not received enough antibodies or have not responded to the vaccine after receiving a third dose of the Chinese national drug.
Turkey, which only gradually relaxed its vaccination restrictions in early March, saw a rebound in just one week, with the cumulative number of confirmed cases surpassing the 3 million mark on the 21st and 20,000 on a single day for four consecutive days. The country has been vaccinating more than 83.6 million people in batches since January this year, and so far more than 8 million people have received the China Kexing vaccine, with more than 5 million people having received two doses, accounting for about 15% of Turkey’s population; the country has also ordered 4.5 million doses of Pfizer vaccine, which is expected to arrive at the end of March.
Chile, which has the highest vaccination rate in South America, ordered 66 million doses of the China Coxin vaccine, and 71-year-old Chilean President Sebastián Piñera went to the airport to personally greet the arrival of the China Coxin vaccine, and later led the vaccination. Since the vaccination program began last month, 29 percent of the 19 million people have received one dose of the vaccine and 15 percent have received two doses, ranking fourth in the world in terms of vaccination efficiency behind places like Israel and the United Kingdom, but the number of confirmed cases has not slowed down.
The number of confirmed cases in Chile reached a record high of 7084 on a single day last Saturday, worse than the outbreak in June last year; according to government records, 26% of deaths in the first three months of this year were due to Wuhan pneumonia, making it the country’s number one killer. According to government records, 26% of deaths in the first three months of this year were due to Wuhan pneumonia, the country’s leading killer. In Brazil, where the Coxin and Oxford vaccines are used, the outbreak has recently worsened, but the blame is generally placed on the slow pace of vaccination, with only 5% of the population having received at least one dose of the vaccine since mid-January.
The Chinese national vaccine, which is claimed to be 79% effective, has been “ineffective” in the United Arab Emirates, and its distributor, G42 health Care, recently confirmed that “a very small percentage” of its citizens had received two doses of the vaccine. G42 chief researcher Zahir stressed that “no matter which vaccine is given, someone may not respond” and that the third dose acts as a booster, boosting the immune system. As of the 20th, 56% of the adult population of the United Arab Emirates, which has a population of 9 million, had received the Chinese Medicine or other vaccines.
Hungary, which ordered the Chinese national vaccine at the end of January, approved the use of the Chinese Convidecia vaccine, which has passed the third phase of testing, as a matter of urgency on the 22nd. The outbreak in Hungary, with a population of 10 million, remains serious, with 10,759 confirmed cases and a record 213 deaths in a single day last Friday, so the Hungarian authorities have gone “beyond” the European Union to find another vaccine from China and Russia. In addition to Hungary, Pakistan and Mexico have also approved Kvisa.
Recent Comments